Doxazosin Mesylate

Doxazosin Mesylate; Active Pharmaceutical Ingredient; EP; CAS 77883-43-3
Web icon

Description

Doxazosin Mesylate is a synthetically synthesized Active Pharmaceutical Ingredient, produced under cGMP, compliant with EP monograph. Its CAS-N° reads 77883-43-3. It is used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia - BPH. Doxazosin mesylate is a selective α-blocker that selectively binds to α1-receptors, thus dilating peripheral blood vessels. This reduces blood pressure and cholesterol levels of the serum. Detailed specification, Certificate of Analysis and samples are available on request.

  • Pharmaceutical products
  • API
  • antihypertensive
  • Doxazosin Mesylate

Product characteristics

CAS
77883-43-3
Product Information
API
Route of Synthesis
Synthetic
Patent Expiry
EU, US - expired
Indication
Antihypertensive, Adrenergic Blocker
Dosage
Oral formulation

Domain icon Manufacturer/ Producer

55218 Ingelheim - Germany

Contact